SlideShare a Scribd company logo

Keratitis – pipeline review, h1 2012

•Download as DOCX, PDF•
•
R
Rose088

Aarkstore.com || Keratitis – Pipeline Review, H1 2012 || Market Research latest report

Business
1 of 4
Aarkstore.com announces, The Latest market research report is available in its vast collection: Keratitis – Pipeline Review, H1 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s, Keratitis - Pipeline Review, H1 2012, provides an overview of the Keratitis therapeutic pipeline. This report provides information on the therapeutic development for Keratitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratitis. Keratitis - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Keratitis. - A review of the Keratitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined
therapeutics. Table of contents: List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Keratitis Overview 6 Therapeutics Development 7 An Overview of Pipeline Products for Keratitis 7 Keratitis Therapeutics under Development by Companies 9 Keratitis Therapeutics under Investigation by Universities/Institutes 10 Mid Clinical Stage Products 11 Comparative Analysis 11 Early Clinical Stage Products 12 Comparative Analysis 12 Pre-Clinical Stage Products 13 Comparative Analysis 13 Keratitis Therapeutics – Products under Development by Companies 14 Keratitis Therapeutics – Products under Investigation by Universities/Institutes 15 Companies Involved in Keratitis Therapeutics Development 16 Menarini Group 16 OPKO Health, Inc. 17 RegeneRx Biopharmaceuticals, Inc. 18 Sirnaomics, Inc. 19 Keratitis – Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Combination Products 21 Assessment by Route of Administration 22 Assessment by Molecule Type 24 Drug Profiles 26 Brivudin - Drug Profile 26 Product Description 26 Mechanism of Action 26
R&D Progress 26 RGN-259 - Drug Profile 27 Product Description 27 Mechanism of Action 27 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H1 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1 Blepharitis – Pipeline Review, H1 2012 Polypoidal Choroidal Vasculopathy – Pipeline Review, H1 2012 Low Cardiac Output Syndrome – Pipeline Review, H1 2012 Keratitis – Pipeline Review, H1 2012 Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) – Pipeline Review, H1 2012 Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012 Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012
Thyroid Gland Disorders – Pipeline Review, H1 2012 Tinea Corporis – Pipeline Review, H1 2012 Pulmonary Fibrosis – Pipeline Review, H1 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com

Recommended

Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 

Recommended

Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
 
Corneal Graft Rejection - Pipeline Insight, 2018
Corneal Graft Rejection - Pipeline Insight, 2018Corneal Graft Rejection - Pipeline Insight, 2018
Corneal Graft Rejection - Pipeline Insight, 2018Market Research Reports, Inc.
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Digna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysisDigna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysisraja1233
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Ambikabasa
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 

More Related Content

What's hot

Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Digna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysisDigna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysisraja1233
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 

What's hot (20)

Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
 
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Corneal Graft Rejection - Pipeline Insight, 2018
Corneal Graft Rejection - Pipeline Insight, 2018Corneal Graft Rejection - Pipeline Insight, 2018
Corneal Graft Rejection - Pipeline Insight, 2018
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Digna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysisDigna biotech, s.l. product pipeline analysis
Digna biotech, s.l. product pipeline analysis
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 

Similar to Keratitis – pipeline review, h1 2012

Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Ambikabasa
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011linda3395
 
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...Scott harm
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Ambikabasa
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Rose088
 
Seborrhea pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Seborrhea pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Ambikabasa
 
Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Ambikabasa
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Ambikabasa
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Rose088
 
Respiratory depression pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Respiratory depression pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Ambikabasa
 
Diarrhea pipeline review, h1 2015
Diarrhea pipeline review, h1 2015Diarrhea pipeline review, h1 2015
Diarrhea pipeline review, h1 2015Ambikabasa
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088
 

Similar to Keratitis – pipeline review, h1 2012 (18)

Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Arrhythmias pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
 
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Seborrhea pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Seborrhea pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 
Respiratory depression pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Respiratory depression pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
Diarrhea pipeline review, h1 2015
Diarrhea pipeline review, h1 2015Diarrhea pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
 

More from Rose088

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineRose088
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionRose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 

More from Rose088 (16)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoption
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 

Recently uploaded

8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...ssuserf63bd7
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppelCorporation
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Servicecallgirls2057
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
Marketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent ChirchirMarketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent Chirchirictsugar
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxMarkAnthonyAurellano
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...lizamodels9
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Timedelhimodelshub1
 

Recently uploaded (20)

8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
Marketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent ChirchirMarketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent Chirchir
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Time
 

Keratitis – pipeline review, h1 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Keratitis – Pipeline Review, H1 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s, Keratitis - Pipeline Review, H1 2012, provides an overview of the Keratitis therapeutic pipeline. This report provides information on the therapeutic development for Keratitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratitis. Keratitis - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Keratitis. - A review of the Keratitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined
  • 2. therapeutics. Table of contents: List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Keratitis Overview 6 Therapeutics Development 7 An Overview of Pipeline Products for Keratitis 7 Keratitis Therapeutics under Development by Companies 9 Keratitis Therapeutics under Investigation by Universities/Institutes 10 Mid Clinical Stage Products 11 Comparative Analysis 11 Early Clinical Stage Products 12 Comparative Analysis 12 Pre-Clinical Stage Products 13 Comparative Analysis 13 Keratitis Therapeutics – Products under Development by Companies 14 Keratitis Therapeutics – Products under Investigation by Universities/Institutes 15 Companies Involved in Keratitis Therapeutics Development 16 Menarini Group 16 OPKO Health, Inc. 17 RegeneRx Biopharmaceuticals, Inc. 18 Sirnaomics, Inc. 19 Keratitis – Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Combination Products 21 Assessment by Route of Administration 22 Assessment by Molecule Type 24 Drug Profiles 26 Brivudin - Drug Profile 26 Product Description 26 Mechanism of Action 26
  • 3. R&D Progress 26 RGN-259 - Drug Profile 27 Product Description 27 Mechanism of Action 27 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H1 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1 Blepharitis – Pipeline Review, H1 2012 Polypoidal Choroidal Vasculopathy – Pipeline Review, H1 2012 Low Cardiac Output Syndrome – Pipeline Review, H1 2012 Keratitis – Pipeline Review, H1 2012 Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) – Pipeline Review, H1 2012 Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012 Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012
  • 4. Thyroid Gland Disorders – Pipeline Review, H1 2012 Tinea Corporis – Pipeline Review, H1 2012 Pulmonary Fibrosis – Pipeline Review, H1 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com